Intravenous (IV) therapy is essential to patient care, but accessing your patient's bloodstream may increase the risk of infection.
The placement of an indwelling vascular access device may elevate a patient's risk for bloodstream infection by creating a portal for bacterial entry. As a result, the design of your needlefree intravenous (IV) connectors plays a substantial role in your ability to prevent bacterial ingress and lower the risk of hospital-acquired bloodstream infections (HA-BSI).2
MicroClave's proven needlefree IV connector technology can be an important element in your efforts to minimize the risk of bloodstream infections.
MicroClave Clear combines proven Clave® technology with a clear housing to help you visualize connector flushing after blood draws or administration while providing an effective microbial barrier against bacteria transfer and contamination.3,4,5
Ideal for a wide range of clinical applications and patient populations, MicroClave Clear is the optimal facility-wide needlefree IV connector.